Home / MEDICAMEQ.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MEDICAMEQ.NS make money? Does MEDICAMEQ.NS have pricing power? What's the Earnings Whisper? Will MEDICAMEQ.NS profit more as the business scales? What is MEDICAMEQ.NS's management track record? Is MEDICAMEQ.NS's current price justified?

Medicamen Biotech Limited

₹285 -$96.55 (-25.30%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹294.6

Day Range

₹280.15₹299

Year Range

₹212.4₹447.65

Market Cap

3.87B

AVG Volume

44.04K

Trailing/Forward PE

35.58/23.1

PEG ratio

1.81

Dividend Yield

0.35%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

MEDICAMEQ.NS Revenue (INR) by year
Period	Revenue (INR)
2026	1.98B
2025	1.63B
2024	1.79B
2023	1.41B
2022	1.15B
2021	1.13B
2020	1.26B
2019	1.23B
2018	1.12B
2017	824.56M

Net Income (INR) · A

MEDICAMEQ.NS Net Income (INR) by year
Period	Net Income (INR)
2026	108.64M
2025	81.46M
2024	98.12M
2023	148.44M
2022	148.97M
2021	121.29M
2020	132.91M
2019	120.25M
2018	98.87M
2017	51.6M

Operating Income (INR) · A

MEDICAMEQ.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	123.69M
2025	67.92M
2024	156.97M
2023	190.05M
2022	177.75M
2021	174.75M
2020	172.75M
2019	154.5M
2018	135.06M
2017	63.59M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Medicamen Biotech Limited

Video analysis: MEDICAMEQ.NS

News: MEDICAMEQ.NS

Similar companies